Prosecution Insights
Last updated: November 04, 2026

UNIVERSIDAD DEL PAÍS VASCO

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

UNIVERSIDAD DEL PAÍS VASCO manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This application is assigned to 1 distinct art unit and 1 distinct examiner, which shows that the university's current patent activity is limited to a single technical review group. This concentration allows the applicant to focus its resources on meeting the specific requirements of one specialized section of the patent office rather than navigating multiple administrative frameworks.

The busiest examiner for the portfolio is STEINKE, SEAN JAMES, who is responsible for 1 pending office action. Because this examiner is the only individual handling the current pending workload, their specific interpretation of the prior art and claim construction will be the determining factor in the prosecution outcome. Practitioners should evaluate the examiner's past decisions within the Biotechnology & Pharmaceuticals sector to anticipate potential hurdles. Tailoring responses to the examiner's established review patterns can help optimize the path toward allowance for this pending application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STEINKE, SEAN JAMES 1 11.8% +43.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17890056 NANOTUBE TRANS-MEMBRANE CHANNELS MIMICKING BIOLOGICAL PORINS STEINKE, SEAN JAMES 18d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17890056 NANOTUBE TRANS-MEMBRANE CHANNELS MIMICKING BIOLOGICAL PORINS STEINKE, SEAN JAMES 18d overdue

Top Art Units

Art UnitApps
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17890056 NANOTUBE TRANS-MEMBRANE CHANNELS MIMICKING BIOLOGICAL PORINS STEINKE, SEAN JAMES 1619 §103§112 Final Rejection 18d overdue Pending Aug 17, 2022

Managing UNIVERSIDAD DEL PAÍS VASCO's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does UNIVERSIDAD DEL PAÍS VASCO have?

UNIVERSIDAD DEL PAÍS VASCO has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most UNIVERSIDAD DEL PAÍS VASCO applications?

Sean James Steinke has the most, with 1 of UNIVERSIDAD DEL PAÍS VASCO's pending office actions.

What technology area are UNIVERSIDAD DEL PAÍS VASCO's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month